103 related articles for article (PubMed ID: 19997820)
1. Immunolocalization of lactoferrin in cartilage-forming neoplasms.
Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
J Orthop Sci; 2009 Nov; 14(6):732-7. PubMed ID: 19997820
[TBL] [Abstract][Full Text] [Related]
2. Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?
Ieni A; Barresi V; Grosso M; Speciale G; Rosa MA; Tuccari G
Pathol Oncol Res; 2011 Jun; 17(2):287-93. PubMed ID: 20972893
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence of lactoferrin in human embryo-fetal bone and cartilage tissues.
Antonio I; Valeria B; Maddalena G; Giovanni T
Cell Biol Int; 2010 Aug; 34(8):845-9. PubMed ID: 20443779
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin immuno-expression in human normal and neoplastic bone tissue.
Ieni A; Barresi V; Grosso M; Rosa MA; Tuccari G
J Bone Miner Metab; 2009; 27(3):364-71. PubMed ID: 19240970
[TBL] [Abstract][Full Text] [Related]
6. The role of noncartilage-specific molecules in differentiation of cartilaginous tumors: lessons from chondroblastoma and chondromyxoid fibroma.
Romeo S; Oosting J; Rozeman LB; Hameetman L; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
Cancer; 2007 Jul; 110(2):385-94. PubMed ID: 17559135
[TBL] [Abstract][Full Text] [Related]
7. Expression of collagen type II, S100B, S100A2 and osteocalcin in chondroblastoma and chondromyxoid fibroma.
Park HR; Park YK; Jang KT; Unni KK
Oncol Rep; 2002; 9(5):1087-91. PubMed ID: 12168078
[TBL] [Abstract][Full Text] [Related]
8. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
Akpalo H; Lange C; Zustin J
Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of lactoferrin in human sporadic renal cell carcinomas.
Giuffrè G; Barresi V; Skliros C; Barresi G; Tuccari G
Oncol Rep; 2007 May; 17(5):1021-6. PubMed ID: 17390038
[TBL] [Abstract][Full Text] [Related]
12. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics.
Romeo S; Hogendoorn PC; Dei Tos AP
Adv Anat Pathol; 2009 Sep; 16(5):307-15. PubMed ID: 19700940
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease.
Tuccari G; Villari D; Giuffrè G; Simone A; Squadrito G; Raimondo G; Barresi G
Histol Histopathol; 2002 Oct; 17(4):1077-83. PubMed ID: 12371135
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years.
Tuccari G; Barresi G
Biometals; 2011 Oct; 24(5):775-84. PubMed ID: 21472415
[TBL] [Abstract][Full Text] [Related]
15. Chondromyxoid fibroma: report of six cases with immunohistochemical studies.
Bleiweiss IJ; Klein MJ
Mod Pathol; 1990 Nov; 3(6):664-6. PubMed ID: 2263591
[TBL] [Abstract][Full Text] [Related]
16. Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia.
Bousdras K; O'Donnell P; Vujovic S; Henderson S; Boshoff C; Flanagan AM
Histopathology; 2007 Sep; 51(3):414-6. PubMed ID: 17727486
[No Abstract] [Full Text] [Related]
17. Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas.
Ieni A; Barresi V; Branca G; Giuffrè G; Rosa MA; Tuccari G
Oncol Lett; 2013 May; 5(5):1536-1540. PubMed ID: 23761817
[TBL] [Abstract][Full Text] [Related]
18. Unusual benign and malignant chondroid tumors of bone. A survey of some mesenchymal cartilage tumors and malignant chondroblastic tumors, including a few multicentric ones, as well as many atypical benign chondroblastomas and chondromyxoid fibromas.
LIGHTENSTEIN L; BERNSTEIN D
Cancer; 1959; 12():1142-57. PubMed ID: 14416919
[No Abstract] [Full Text] [Related]
19. Immunolocalization of lactoferrin in surgically resected pigmented skin lesions.
Tuccari G; Giuffrè G; Scarf R; Simone A; Todaro P; Barresi G
Eur J Histochem; 2005; 49(1):33-8. PubMed ID: 15823792
[TBL] [Abstract][Full Text] [Related]
20. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
Dancer JY; Henry SP; Bondaruk J; Lee S; Ayala AG; de Crombrugghe B; Czerniak B
Hum Pathol; 2010 Dec; 41(12):1788-93. PubMed ID: 21078438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
